The bill titled "An Act Promoting Equity in Medicaid Coverage for Fertility Health Care" mandates the Commissioner of Social Services to amend the Medicaid state plan to include coverage for fertility diagnostic care, fertility preservation services, and fertility treatment. This includes coverage for medically necessary ovulation-enhancing drugs and a minimum of three cycles of ovulation-enhancing medication treatment. The bill also defines "infertility" based on various medical conditions and circumstances affecting an individual's ability to conceive, including the inability to achieve pregnancy after six months of unprotected intercourse and age-related factors.

Furthermore, the bill requires the Commissioner to consult with the Centers for Medicare and Medicaid Services by July 1, 2026, to report on the costs and benefits of including in-vitro fertilization (IVF) as a covered benefit under Medicaid. This report will address necessary Medicaid waivers and anticipated state costs. The effective date for these provisions is set for January 1, 2026. The bill updates the definition of medically necessary services under Medicaid to align with established medical practices and guidelines, ensuring comprehensive coverage for fertility-related services without specifying any deletions from current law.